In the current study, we investigated the therapeutic potency of the AFP vaccination strategy (AFP lentivirus prime plus AFP499 peptide boost) in the c-MYC/Mcl1 and cMet/β-catenin murine HCC models. Here, MET is linked to hepatocellular carcinoma.